ED Telehealth (PDE5 Inhibitors), considered.
PDE5 inhibitors are among the most prescribed and best-studied drugs in modern pharmacology. Telehealth removed the friction of an in-person urology visit for what is, for most patients, a pharmacological problem with a pharmacological solution.
What PDE5 inhibitors actually do.
These drugs inhibit phosphodiesterase type 5, an enzyme that breaks down cGMP — the molecule that mediates smooth muscle relaxation in penile arteries. They do not 'cause' an erection; they enable a normal erection in response to sexual stimulation.
Sildenafil acts in 30–60 minutes, lasts 4–6 hours. Tadalafil acts in 30 minutes, lasts 24–36 hours and is the typical choice for daily low-dose protocols (2.5–5 mg). Vardenafil and avanafil have intermediate profiles.
When ED is a signal, not the problem.
ED is often the first vascular symptom of cardiovascular disease — penile arteries are smaller and more sensitive to endothelial dysfunction than coronary arteries. New-onset ED in men over 40 warrants a basic cardiovascular workup (lipid panel, blood pressure, fasting glucose, family history review).
Other underlying contributors: hypogonadism (low T), pelvic floor dysfunction, SSRIs and other medications, alcohol, sleep apnea, relationship factors, performance anxiety. PDE5 inhibitors treat the symptom; the underlying contributor often deserves separate attention.
Daily low-dose vs on-demand.
On-demand sildenafil (50–100 mg) or tadalafil (10–20 mg) is the standard for occasional use. Daily tadalafil (2.5–5 mg) is approved for both ED and benign prostatic hyperplasia and is preferred by many patients who dislike the timing logistics of on-demand dosing.
Daily low-dose tadalafil also has emerging evidence for endothelial health benefits beyond ED — though the size of those benefits and their clinical relevance for asymptomatic users is debated.
Common questions.
Are these drugs safe?
Sildenafil has been on market since 1998, tadalafil since 2003. The safety profile is among the best-characterized in pharmacology. Major caveat: any concurrent use of nitrates (for chest pain, including poppers/amyl nitrite) is contraindicated and dangerous.
Will I become dependent?
Pharmacologically, no. Psychologically, some men report performance anxiety once they stop, which is a different (and addressable) issue.
Telehealth vs urologist visit — which?
For uncomplicated ED in men with no cardiovascular red flags, telehealth is appropriate. For new-onset ED with risk factors, men under 40, painful curvature, or symptoms suggesting hormonal cause, an in-person visit with cardiovascular and hormonal workup is worth the additional friction.
What if these don't work?
About 20–30% of men do not respond adequately to oral PDE5 inhibitors. Second-line options: intracavernosal injections (alprostadil), intraurethral suppositories, vacuum erection devices, penile implants. A urologist consultation is appropriate at that point.
Can I combine them with TRT?
Yes. Many men with low T find their ED improves on TRT alone; some need both. There are no significant interactions.